Tag: biomedical
-
RNA Therapy Helps Reduce Preeclampsia Symptoms
Experimental treatments with engineered RNA are shown in lab animals to reduce symptoms of preeclampsia, a disorder causing high blood pressure in pregnant women.
-
Trial Shows Treatment Prevents Peanut Allergy Reactions
Final results from a clinical trial show a preventive treatment desensitizes children and adolescents with peanut allergies against reaction-causing proteins in peanuts for one year.
-
Update – Verily Suspends Glucose-Sensing Contact Lens Project
An initiative developing a contact lens that measures blood glucose levels in tear fluid is now on hold, according to Verily Life Sciences, a division of Alphabet, the parent company of Google.
-
Trial Testing Non-Opioid Pellet Implant for Sciatica Pain
A clinical trial to test a tiny implanted pellet containing a non-opioid pain killer began treating participants to relieve leg and back pain from sciatica.
-
Survey Shows Sharp Rise in Teen E-Cigarette Use
New data from a continuing survey of smoking among school-age children shows large increases in electronic cigarette use in high school and middle school children in just the past year.
-
Radio Frequency Tags, A.I. Designed to Detect Unsafe Food
A computer engineering team designed a simple, inexpensive system for detecting food quality with radio-frequency tags applied to consumer products and machine learning algorithms.
-
Trial Tests Diabetes Mgmt. Program vs. Smartphone Glucose Meter
A new clinical trial is testing a diabetes management program that includes Internet-connected glucose meters and one-on-one coaching against smartphone-enabled glucose meters alone.
-
DNA-Encoded Synthetic Antibodies Protect Against Ebola
Synthetic antibodies derived from survivors of Ebola infections are shown to be quick and simple to develop, and in lab mice to provide long-term protection against against Ebola viruses.
-
Biotechs to Develop Personal Cancer-Killing Virus Vaccines
Two biotechnology companies developing engineered viruses as cancer therapies plan to create personalized treatments for solid tumors with viruses that harness the immune system.
-
RNA Therapeutics Company Raises $30M in First Venture Round
A company spun-off from a university biochemistry lab is raising $30 million to fund discovery of treatments targeting RNA, genetic material instructing protein production in cells.